华泰联合证券有限责任公司 关于芯联集成电路制造股份有限公司 发行股份及支付现金购买资产 暨关联交易 之 独立财务顾问报告 （上会稿） 独立财务顾问 二〇二五年六月 华泰联合证券关于芯联集成发行股份及支付现金购买资产暨关联交易之独立财务顾问报告 独立财务顾问声明和承诺 华泰联合证券有限责任公司（以下简称"华泰联合"、"本独立财务顾问"） 接受芯联集成电路制造股份有限公司（以下简称"芯联集成"、"上市公司"或"公 司"）委托，担任本次发行股份及支付现金购买资产暨关联交易（以下简称"本 次交易"）的独立财务顾问，就该事项向上市公司全体股东提供独立意见，并制 作本独立财务顾问报告。 本独立财务顾问报告是依据《中华人民共和国公司法》《中华人民共和国证 券法》《上市公司重大资产重组管理办法》《上市公司并购重组财务顾问业务管理 办法》《公开发行证券的公司信息披露内容与格式准则第 26 号——上市公司重大 资产重组》《上市公司监管指引第 9 号——上市公司筹划和实施重大资产重组的 监管要求》和《上海证券交易所上市公司重大资产重组审核规则》等法律法规及 文件的规定和要求，以及证券行业公认的业务标准、道德规范，经过审慎调查， 本 ...

证券代码：688469 证券简称：芯联集成 上市地：上海证券交易所 芯联集成电路制造股份有限公司 发行股份及支付现金购买资产 暨关联交易报告书（草案） （上会稿） | 项 目 | 名 称 | | --- | --- | | 购买资产交易对方 | 绍兴滨海新区芯兴股权投资基金合伙企业（有限合伙）、深圳 | | | 市远致一号私募股权投资基金合伙企业（有限合伙）、厦门辰 | | | 途华辉创业投资合伙企业（有限合伙）、厦门辰途华明创业投 | | | 资基金合伙企业（有限合伙）、厦门辰途华景创业投资基金合 | | | 伙企业（有限合伙）、珠海横琴强科二号股权投资合伙企业 | | | （有限合伙）、张家港毅博企业管理中心（有限合伙）、尚融 | | | 创新（宁波）股权投资中心（有限合伙）、井冈山复朴新世纪 | | | 股权投资合伙企业（有限合伙）、华民科文（青岛）创业投资 | | | 基金合伙企业（有限合伙）、无锡芯朋微电子股份有限公司、 | | | 广东导远科技有限公司、广东辰途十六号创业投资合伙企业 | | | （有限合伙）、广州辰途十五号创业投资基金合伙企业（有限 | | | 合伙）、锐石创芯（重庆）科技股份有 ...

证券代码：688469 证券简称：芯联集成 上市地：上海证券交易所 芯联集成电路制造股份有限公司 发行股份及支付现金购买资产 暨关联交易报告书（草案）摘要 （上会稿） | 项 目 | 名 称 | | --- | --- | | 购买资产交易对方 | 绍兴滨海新区芯兴股权投资基金合伙企业（有限合伙）、深圳 | | | 市远致一号私募股权投资基金合伙企业（有限合伙）、厦门辰 | | | 途华辉创业投资合伙企业（有限合伙）、厦门辰途华明创业投 | | | 资基金合伙企业（有限合伙）、厦门辰途华景创业投资基金合 | | | 伙企业（有限合伙）、珠海横琴强科二号股权投资合伙企业 | | | （有限合伙）、张家港毅博企业管理中心（有限合伙）、尚融 | | | 创新（宁波）股权投资中心（有限合伙）、井冈山复朴新世纪 | | | 股权投资合伙企业（有限合伙）、华民科文（青岛）创业投资 | | | 基金合伙企业（有限合伙）、无锡芯朋微电子股份有限公司、 | | | 广东导远科技有限公司、广东辰途十六号创业投资合伙企业 | | | （有限合伙）、广州辰途十五号创业投资基金合伙企业（有限 | | | 合伙）、锐石创芯（重庆）科技股 ...

证券代码：688469 证券简称：芯联集成 公告编号：2025-031 芯联集成电路制造股份有限公司 关于收到上海证券交易所审核中心意见落实函的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 特此公告。 1 芯联集成电路制造股份有限公司董事会 2025 年 6 月 17 日 芯联集成电路制造股份有限公司（以下简称"公司"）拟发行股份及支付现 金购买绍兴滨海新区芯兴股权投资基金合伙企业（有限合伙）、深圳市远致一号 私募股权投资基金合伙企业（有限合伙）等 15 名交易对方合计持有的芯联越州 集成电路制造（绍兴）有限公司 72.33%股权（以下简称"本次交易"）。 2025 年 6 月 16 日，公司收到上海证券交易所（以下简称"上交所"）出具 的《关于芯联集成电路制造股份有限公司发行股份及支付现金购买资产暨关联交 易申请的审核中心意见落实函》（上证科审（并购重组）〔2025〕16 号）（以下简 称"《落实函》"）。根据《公司法》《证券法》《上市公司重大资产重组管理办法》 《上海证券交易所上市公司重大资产重组审核规则》等法律、 ...

Core Viewpoint - The rapid development of the private equity investment sector has led to A-share listed companies engaging in various forms of private equity investments to discover and incubate quality targets within their industry and supply chains, while also expanding their investment paths. CVC funds led by listed companies have become a crucial force in the private equity market, but they face scrutiny due to potential conflicts of interest and regulatory restrictions, particularly after the implementation of the "Private Investment Fund Registration and Filing Measures" on May 1, 2023 [1][14]. Pathways for Establishing Private Fund Managers - A total of 16 private fund managers related to A-share listed companies have been approved by the Asset Management Association of China (AMAC) from May 1, 2023, to May 1, 2025. These include 1 wholly-owned subsidiary, 4 controlled by listed companies, 10 directly or indirectly invested by listed companies, and 1 established by the actual controller of a listed company [2]. Pathway One: Wholly Owned Establishment - Listed companies can establish private fund managers wholly owned by themselves. This pathway is subject to strict regulatory scrutiny due to the potential classification as "quasi-financial" businesses [3][6]. Pathway Two: Controlling Establishment - Listed companies can also establish controlling private fund managers where they hold more than 50% of the shares. However, this pathway has seen limited success due to regulatory concerns, with only 4 such managers registered since the new regulations [3][4]. Pathway Three: Joint Establishment with Third Parties - This pathway involves listed companies partnering with third parties to establish private fund managers, where the listed company acts as a financial or strategic investor. This has proven to be a more viable option, with 10 managers established under this model since the new regulations [4][5]. Pathway Four: Establishment by Actual Controllers - Actual controllers of listed companies can establish private fund managers directly. This pathway is less restricted, provided that the listed company does not directly invest in the fund manager [6][10]. Compliance Points for Each Pathway - Pathways one and two face stricter regulatory requirements due to the direct control by listed companies, necessitating good financial health and adherence to internal decision-making and disclosure procedures [7][8]. - Pathway three requires careful attention to the legitimacy of the investment purpose and compliance with disclosure obligations, especially regarding related party transactions [10][11]. - Pathway four mandates that the actual controller disclose their relationship with the fund manager and comply with related party transaction regulations if the listed company invests in the fund [12][13]. Risk Prevention Measures - Listed companies and their affiliates must be vigilant against risks such as insider trading, conflicts of interest, and the misuse of non-public information. Establishing robust internal controls and compliance mechanisms is essential to mitigate these risks [12][13]. Conclusion - The article summarizes four pathways for listed companies to establish private fund managers, highlighting the regulatory landscape and compliance requirements. The core controversy revolves around the "quasi-financial" risks associated with these activities, emphasizing the need for a balance between industrial investment demands and financial regulatory boundaries. Future policies may exhibit flexibility, recognizing the value of supporting the real economy while preventing unchecked capital expansion [14].

Group 1 - The core transaction involves issuing shares and cash to acquire a 72.33% stake in ChipLink Yuezhou Integrated Circuit Manufacturing Co., Ltd for a total price of 589,661.33 million yuan [11][12][14] - The transaction is expected to enhance the company's capabilities in power semiconductors and MEMS, leveraging advanced production lines and technology [14][19] - ChipLink Yuezhou is positioned to capitalize on the growing demand for SiC MOSFETs and high-voltage analog ICs, particularly in the automotive and industrial control sectors [14][19] Group 2 - The transaction will increase the company's total share capital from 7,069,085,200 shares to 8,382,687,172 shares, with no change in control or actual controller [15][17] - Post-transaction, the company's equity attributable to shareholders is expected to rise, although the net profit may be impacted due to the current losses of the acquired company [18][19] - The acquisition is anticipated to improve the overall asset quality and financial condition of the company in the long term [19]

证券代码：688469 证券简称：芯联集成 上市地：上海证券交易所 芯联集成电路制造股份有限公司 发行股份及支付现金购买资产 暨关联交易报告书（草案）摘要 （修订稿） | 项 目 | 名 称 | | --- | --- | | 购买资产交易对方 | 绍兴滨海新区芯兴股权投资基金合伙企业（有限合伙）、深圳 | | | 市远致一号私募股权投资基金合伙企业（有限合伙）、厦门辰 | | | 途华辉创业投资合伙企业（有限合伙）、厦门辰途华明创业投 | | | 资基金合伙企业（有限合伙）、厦门辰途华景创业投资基金合 | | | 伙企业（有限合伙）、珠海横琴强科二号股权投资合伙企业 | | | （有限合伙）、张家港毅博企业管理中心（有限合伙）、尚融 | | | 创新（宁波）股权投资中心（有限合伙）、井冈山复朴新世纪 | | | 股权投资合伙企业（有限合伙）、华民科文（青岛）创业投资 | | | 基金合伙企业（有限合伙）、无锡芯朋微电子股份有限公司、 | | | 广东导远科技有限公司、广东辰途十六号创业投资合伙企业 | | | （有限合伙）、广州辰途十五号创业投资基金合伙企业（有限 | | | 合伙）、锐石创芯（重庆）科技股 ...

证券代码：688469 证券简称：芯联集成 上市地：上海证券交易所 芯联集成电路制造股份有限公司 发行股份及支付现金购买资产 暨关联交易报告书（草案） （修订稿） | 项 目 | 名 称 | | --- | --- | | 购买资产交易对方 | 绍兴滨海新区芯兴股权投资基金合伙企业（有限合伙）、深圳 | | | 市远致一号私募股权投资基金合伙企业（有限合伙）、厦门辰 | | | 途华辉创业投资合伙企业（有限合伙）、厦门辰途华明创业投 | | | 资基金合伙企业（有限合伙）、厦门辰途华景创业投资基金合 | | | 伙企业（有限合伙）、珠海横琴强科二号股权投资合伙企业 | | | （有限合伙）、张家港毅博企业管理中心（有限合伙）、尚融 | | | 创新（宁波）股权投资中心（有限合伙）、井冈山复朴新世纪 | | | 股权投资合伙企业（有限合伙）、华民科文（青岛）创业投资 | | | 基金合伙企业（有限合伙）、无锡芯朋微电子股份有限公司、 | | | 广东导远科技有限公司、广东辰途十六号创业投资合伙企业 | | | （有限合伙）、广州辰途十五号创业投资基金合伙企业（有限 | | | 合伙）、锐石创芯（重庆）科技股份有 ...

芯联集成电路制造股份有限公司 关于发行股份及支付现金购买资产暨关联交易 报告书（草案）修订说明的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 芯联集成电路制造股份有限公司（以下简称"公司"）拟发行股份及支付现 金购买绍兴滨海新区芯兴股权投资基金合伙企业（有限合伙）、深圳市远致一号 私募股权投资基金合伙企业（有限合伙）等 15 名交易对方合计持有的芯联越州 集成电路制造（绍兴）有限公司 72.33%股权（以下简称"本次交易"）。 | | 章节 | 修订情况 | | --- | --- | --- | | | 重大事项提示 | 更新本次重组交易对方的锁定期安排 | | 第一章 | 本次交易概况 | 更新本次重组交易对方的锁定期安排 | | 第二章 | 上市公司基本情况 | 更新上市公司前十大股东信息；更新上市公司主要财务数据 | | | | 及财务指标 | | 第五章 | 发行股份情况 | 更新本次重组交易对方的锁定期安排 | 证券代码：688469 证券简称：芯联集成 公告编号：2025-030 2025 年 1 月 1 ...

Core Viewpoint - The company, ChipLink Integrated Circuit Manufacturing Co., Ltd., is undergoing a name change and has recently experienced a decline in stock price since its IPO, which has led to a state of underperformance in the market [1][2]. Group 1: Company Name Change and Stock Performance - The company announced a change in its Chinese name from "绍兴中芯集成电路制造股份有限公司" to "芯联集成电路制造股份有限公司," with the stock abbreviation changing from "中芯集成" to "芯联集成" effective December 6, 2023 [1]. - As of June 12, 2023, the stock price closed at 4.52 yuan, reflecting a decline of 1.31% [1]. - The stock reached a peak price of 6.96 yuan on its first trading day but is currently in a state of decline [2]. Group 2: IPO and Fundraising Details - The company completed its IPO on May 10, 2023, issuing 169,200,000 shares initially, with a total fundraising amount of 962,748,000 yuan before the exercise of the over-allotment option [2][3]. - After fully exercising the over-allotment option, the total number of shares issued increased to 194,580,000, raising a total of 1,107,160,200 yuan [2][4]. - The net proceeds from the IPO, after deducting issuance costs, were 937,276,550 yuan before the over-allotment and 1,078,341,700 yuan after [2][4]. Group 3: Use of Proceeds - The company plans to use the raised funds for projects including the technological transformation of MEMS and power device chip manufacturing and packaging testing production bases, as well as for working capital [2].